메뉴 건너뛰기




Volumn 18, Issue 6, 2001, Pages 421-423

Dying at home: Emergency medications for terminal symptoms

Author keywords

emergency; hospice; palliative care; symptoms; terminal care

Indexed keywords

ANTIEMETIC AGENT; ANXIOLYTIC AGENT; ATROPINE; CHLORPROMAZINE; DIAZEPAM; MORPHINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT;

EID: 0035512320     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990910101800614     Document Type: Article
Times cited : (28)

References (7)
  • 1
    • 0031693299 scopus 로고    scopus 로고
    • Influence of patient preferences and local health system characteristics on the place of death. SUPPORT Investigators: Study to understand prognoses and preferences for risks and outcomes of treatment
    • Pritchard RS, Fisher ES, Teno JM, et al.: Influence of patient preferences and local health system characteristics on the place of death. SUPPORT Investigators: Study to understand prognoses and preferences for risks and outcomes of treatment. J American Geriatrics Society. 1998; 46(10): 1242-1250.
    • (1998) J American Geriatrics Society , vol.46 , Issue.10 , pp. 1242-1250
    • Pritchard, R.S.1    Fisher, E.S.2    Teno, J.M.3
  • 2
    • 0025617945 scopus 로고
    • The last 48 hours of life
    • Lichter I, Hunt E: The last 48 hours of life. J Palliative Care. 1990; 6(4): 7-15.
    • (1990) J Palliative Care , vol.6 , Issue.4 , pp. 7-15
    • Lichter, I.1    Hunt, E.2
  • 3
    • 0033956530 scopus 로고    scopus 로고
    • The dying cancer patient
    • Seminars in Oncology
    • Nelson KA, Walsh D, Brady D, et al.: The dying cancer patient. Seminars in Oncology. 2000; 27(1):1-7.
    • (2000) , vol.27 , Issue.1 , pp. 1-7
    • Nelson, K.A.1    Walsh, D.2    Brady, D.3
  • 4
    • 0033956529 scopus 로고    scopus 로고
    • Symptom control in advanced cancer: Important drugs and routes of administration
    • Seminars in Oncology
    • Walsh D, Doona M, Molnar M, et al.: Symptom control in advanced cancer: Important drugs and routes of administration. Seminars in Oncology. 2000; 27(1): 69-83.
    • (2000) , vol.27 , Issue.1 , pp. 69-83
    • Walsh, D.1    Doona, M.2    Molnar, M.3
  • 5
    • 0025740254 scopus 로고
    • Plasma morphine and morphine-6-glucuronide patterns in cancer patients after oral, subcutaneous, sublabial and rectal short-term administration
    • Breda M, Bianchi M, Riapamonti C, et al.: Plasma morphine and morphine-6-glucuronide patterns in cancer patients after oral, subcutaneous, sublabial and rectal short-term administration. Int J Clin Pharmacol Res. 1991; 11(2): 93-97.
    • (1991) Int J Clin Pharmacol Res , vol.11 , Issue.2 , pp. 93-97
    • Breda, M.1    Bianchi, M.2    Riapamonti, C.3
  • 6
    • 0028128309 scopus 로고
    • The use of chlorpromazine for symptom control in dying cancer patients
    • McIver B, Walsh D, Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage. 1994; 9: 341-345.
    • (1994) J Pain Symptom Manage , vol.9 , pp. 341-345
    • McIver, B.1    Walsh, D.2    Nelson, K.3
  • 7
    • 0021952488 scopus 로고
    • Chlorpromazine: a specific effect on breathlessness?
    • Neill PA, Morton PB Stark, RD. Chlorpromazine: a specific effect on breathlessness? Br. J Clin Pharmacol. 1985; 19: 793-797.
    • (1985) Br. J Clin Pharmacol , vol.19 , pp. 793-797
    • Neill, P.A.1    Morton, P.B.2    Stark, R.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.